HPLC, UHPLC
LC-MS in use to fingerprint PHY906
Aug 19 2010
PHY906 is effective at reducing gastrointestinal toxicity resulting from treatment with CPT-11, a chemotherapy drug also known as irinotecan, the researchers write in Science Translational Medicine.
The 1,800-year-old formulation is now the subject of LC-MS investigations to learn more about its structure, reports Nature.
Yung-Chi Cheng, a pharmacologist at Yale University who is working on the project, tells the news provider: "This is a new paradigm of drug development. It's a typical example of West meets East."
In their study, the scientists note how PHY906 is able to increase anti-tumour effects during treatment with CPT-11, while also reducing the amount of weight lost by the patient.
They add that the anti-toxicity effects witnessed occur simultaneously through a number of different mechanisms when the herbal medicine is administered to chemotherapy participants.
Digital Edition
Chromatography Today - Buyers' Guide 2022
October 2023
In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Events
Jan 20 2025 Amsterdam, Netherlands
Feb 03 2025 Dubai, UAE
Feb 05 2025 Guangzhou, China
Mar 01 2025 Boston, MA, USA
Mar 04 2025 Berlin, Germany